.png)
Amgen Data Breach Lawsuit Investigation
Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in data breach cases, is investigating the Amgen Inc. data breach.
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
About Amgen
Amgen Inc. is a major American biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen develops, manufactures and delivers human therapeutics for serious diseases.
Amgen's core business focuses on biologic medicines used to treat cancer, heart disease, osteoporosis, autoimmune disorders and rare diseases.
What Happened?
In July 2026, Amgen discovered unauthorized activity involving data stored in cloud environments hosted by third-party providers.
The company activated its cybersecurity response plan, engaged external forensic experts and notified relevant authorities. Amgen disclosed the incident to the U.S. Securities and Exchange Commission on July 29, 2026.
The company reported that the following types of information were involved in the breach:
Information Exposed:
- Proprietary data
- Patient protected health information
- Other information
Amgen stated that they are still assessing the full impact of the incident and are working with law enforcement and cybersecurity experts.
You May Be Entitled to Compensation
If your information was exposed in the Amgen data breach, you may be eligible for compensation. This could include reimbursement for out-of-pocket expenses, credit monitoring services, or damages related to identity theft or privacy violations. Lawyers are ready to help you determine your eligibility and guide you through the process.
To take the next step, complete the below form to join the lawsuit investigation and protect your rights.
.svg)